TY - JOUR
T1 - Toxoplasma gondii as a Risk Factor for Early-Onset Schizophrenia
T2 - Analysis of Filter Paper Blood Samples Obtained at Birth
AU - Mortensen, Preben Bo
AU - Nørgaard-Pedersen, Bent
AU - Waltoft, Berit Lindum
AU - Sørensen, Tina L.
AU - Hougaard, David
AU - Torrey, E. Fuller
AU - Yolken, Robert H.
N1 - Funding Information:
This study was supported by the Stanley Medical Research Institute. The National Centre for Register-Based Research is supported financially by the Danish National Research Foundation. Psychiatric epidemiological research at the National Centre for Register-Based Research is, in part, funded through a collaborative agreement with Centre for Basic Psychiatric Research, Psychiatric Hospital in Aarhus.
Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2007/3/1
Y1 - 2007/3/1
N2 - Background: Infections during fetal life or neonatal period, including infections with Toxoplasma gondii, may be associated with a risk for schizophrenia and other mental disorders. The objectives of this study were to study the association between serological markers for maternal and neonatal infection and the risk for schizophrenia, related psychoses, and affective disorders in a national cohort of newborns. Methods: This study was a cohort-based, case-control study combining data from national population registers and patient registers and a national neonatal screening biobank in Denmark. Patients included persons born in Denmark in 1981 or later followed up through 1999 with respect to inpatient or outpatient treatment for schizophrenia or related disorders (ICD-10 F2) or affective disorders (ICD-10 F3). Results: Toxoplasma gondii immunoglobulin G (IgG) levels corresponding to the upper quartile among control subjects were significantly associated with schizophrenia risk (odds ratio [OR] = 1.79, p = .045) after adjustment for urbanicity of place of birth, year of birth, gender, and psychiatric diagnoses among first-degree relatives. There was no significant association between any marker of infection and other schizophrenia-like disorders or affective disorders. Conclusions: Our study supports an association between Toxoplasma gondii and early-onset schizophrenia. Further studies are needed to establish if the association is causal and if it generalizes to cases with onset after age 18.
AB - Background: Infections during fetal life or neonatal period, including infections with Toxoplasma gondii, may be associated with a risk for schizophrenia and other mental disorders. The objectives of this study were to study the association between serological markers for maternal and neonatal infection and the risk for schizophrenia, related psychoses, and affective disorders in a national cohort of newborns. Methods: This study was a cohort-based, case-control study combining data from national population registers and patient registers and a national neonatal screening biobank in Denmark. Patients included persons born in Denmark in 1981 or later followed up through 1999 with respect to inpatient or outpatient treatment for schizophrenia or related disorders (ICD-10 F2) or affective disorders (ICD-10 F3). Results: Toxoplasma gondii immunoglobulin G (IgG) levels corresponding to the upper quartile among control subjects were significantly associated with schizophrenia risk (odds ratio [OR] = 1.79, p = .045) after adjustment for urbanicity of place of birth, year of birth, gender, and psychiatric diagnoses among first-degree relatives. There was no significant association between any marker of infection and other schizophrenia-like disorders or affective disorders. Conclusions: Our study supports an association between Toxoplasma gondii and early-onset schizophrenia. Further studies are needed to establish if the association is causal and if it generalizes to cases with onset after age 18.
KW - Affective disorder
KW - Toxoplasma gondii
KW - neonatal
KW - psychosis
KW - schizophrenia
UR - http://www.scopus.com/inward/record.url?scp=33847283324&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33847283324&partnerID=8YFLogxK
U2 - 10.1016/j.biopsych.2006.05.024
DO - 10.1016/j.biopsych.2006.05.024
M3 - Article
C2 - 16920078
AN - SCOPUS:33847283324
SN - 0006-3223
VL - 61
SP - 688
EP - 693
JO - Biological Psychiatry
JF - Biological Psychiatry
IS - 5
ER -